Etios Pharmaceuticals Private Limited
About Etios Pharmaceuticals Private Limited
Data last updated:
Etios Pharmaceuticals Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 05 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U74900JH2011PTC015060. Its GSTIN is 20AACCE8187H1ZO (Jharkhand).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.1 Lakh. It is led by directors Imam Akhter and Mukesh Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ram Tara Niwas Anand Vihar Kadru, Ranchi, Jharkhand, India – 834002.
As per the financials filed for FY 2024, the company reported a revenue of ₹34.15 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹46,198 (net margin 1.4%) and EBITDA of ₹2.17 Lakh (EBITDA margin 6.3%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Etios Pharmaceuticals Private Limited's registered office is in Ranchi, Jharkhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRam Tara Niwas Anand Vihar Kadru, Ranchi, Jharkhand, India – 834002
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Etios Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Etios Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Etios Pharmaceuticals Private Limited, buy the company report.
Financials of Etios Pharmaceuticals Private Limited
FY 2025 filings availableEtios Pharmaceuticals Private Limited reported revenue of ₹34.15 Lakh (down 12% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 12% fall in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹46,198 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Etios Pharmaceuticals Private Limited, buy the company report.
Board of directors of Etios Pharmaceuticals Private Limited
Etios Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Imam Akhter | Director | 05 Sep 2011 | 15 Years 1 Months | Current |
| Mukesh Kumar Singh | Director | 05 Sep 2011 | 15 Years 1 Months | Current |
Peer comparison
Etios Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Goodness Pharmaceuticals Private Limited | ₹34.21 Lakh (FY 2022) | 6.0% | Aligarh, Uttar Pradesh, India | |||
| Craicean Pharmaceuticals Private Limited | ₹34.19 Lakh (FY 2024) | 8.0% | Lucknow, Uttar Pradesh, India | |||
| Indigrammy Pharmaceuticals Private Limited | ₹34.18 Lakh (FY 2025) | 17.0% | Thane, Maharashtra, India | |||
| Solway Pharmaceuticals Private Limited | ₹34.16 Lakh (FY 2025) | -11.0% | Ambala Cantt, Haryana, India | |||
| Etios Pharmaceuticals Private Limitedthis company | ₹34.15 Lakh (FY 2024) | ₹46,198 | 1.4% | -12.0% | Ranchi, Jharkhand, India |
To see the full peer comparison of Etios Pharmaceuticals Private Limited, buy the company report.
Auditor
Etios Pharmaceuticals Private Limited is audited by AJOY CHHABRA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJOY CHHABRA & CO. | FY 2017 | 012594C |
Shareholding
The shareholding of Etios Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Etios Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Etios Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Etios Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Etios Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AACCE8187H1ZO | Jharkhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Etios Pharmaceuticals Private Limited, buy the company report.
Recent activity
Etios Pharmaceuticals Private Limited has 7 board changes on record since 2011: 2 appointments and 5 cessations. The latest: Md Zaffer Imam Ansari ceased to be Director on 28 Dec 2018.
Frequently asked questions
Etios Pharmaceuticals is an active private limited company based in Ranchi, Jharkhand, India. The company works in other wholesale, within the trading industry. It was incorporated on 05 September 2011 (15+ years old) and is registered under CIN U74900JH2011PTC015060.
Etios Pharmaceuticals has 2 current directors:
- Imam Akhter - Director
- Mukesh Kumar Singh - Director
The latest financial statements of Etios Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Etios Pharmaceuticals is 20AACCE8187H1ZO, registered in Jharkhand.
The CIN (Corporate Identification Number) of Etios Pharmaceuticals is U74900JH2011PTC015060. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Etios Pharmaceuticals was incorporated on 05 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Etios Pharmaceuticals by revenue are Goodness Pharmaceuticals Private Limited, Craicean Pharmaceuticals Private Limited, Indigrammy Pharmaceuticals Private Limited, Solway Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Md Zaffer Imam Ansari ceased to be Director on 28 Dec 2018. Bhaiya Niraj Sinha ceased to be Director on 02 Sep 2013. Manoj Kumar Upadhyay ceased to be Director on 02 Sep 2013. Etios Pharmaceuticals has 7 board changes on record in total.
The registered office of Etios Pharmaceuticals is at Ram Tara Niwas Anand Vihar Kadru, Ranchi, Jharkhand, India – 834002.
Etios Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Etios Pharmaceuticals is compliant as of 05 July 2026. The company is actively filing with the Registrar of Companies.